COVID-19 Infection
📧 Sign up to get email alerts when something new happens for COVID-19 Infection.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-06EMA Authorised: Spikevax (previously COVID-19 Vaccine Moderna) (single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the viral spike (S) protein of SARS-CoV-2) — Moderna Biotech Spain, S.L.
European Medicines Agency authorises Spikevax (Moderna COVID-19 vaccine) for use in the EU.
-
EMA approval · 2026-06-15EMA Authorised: Tuyory — Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.)
Tuyory has been authorised by the EMA for multiple indications including rheumatoid arthritis, juvenile arthritis, cytokine release syndrome…
-
EMA approval · 2026-06-09EMA Authorised: Avtozma (tocilizumab) — Celltrion Healthcare Hungary Kft.
Avtozma (tocilizumab) has been authorised in the EU for rheumatoid arthritis, juvenile idiopathic arthritis, cytokine release syndrome, and …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: NCI COVID-19 in Cancer Patients, NCCAPS Study
A National Cancer Institute study (NCT04387656) evaluating COVID-19 infection in cancer patients is ongoing, with the trial status currently…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients [Phase 1]
This Phase 1 clinical trial at MD Anderson is evaluating the feasibility, safety, and efficacy of genetically engineered glucocorticoid rece…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Impact of the COVID-19 Pandemic and HRQOL in Cancer Patients and Survivors
This MD Anderson-led clinical trial assesses how the COVID-19 pandemic has affected health-related quality of life in cancer patients and su…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: The Impact of COVID-19 on Pulmonary Procedures
A clinical trial update from MD Anderson Cancer Center notes that a study examining the impact of COVID-19 on pulmonary procedures is curren…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection [Phase 3]
A Phase 3 trial evaluating Plitidepsin versus control in moderate COVID-19 infection was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2023-12-11Clinical Trial Update: A Trial Looking at the Use of Camostat in People Who Have Tested Positive for Coronavirus (COVID-19) (SPIKE-1) [Phase 2]
Phase 2 trial investigating camostat for COVID-19 infection; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-11-18Clinical Trial Update: An Open-Label Study of Apabetalone in Covid Infection [Phase 2, Phase 3]
Open-label study of apabetalone in COVID-19 infection was terminated after Phase 2/3; no conclusive results reported here.
-
CLINICAL_TRIALS trial_result · 2023-11-13Clinical Trial Update: "CHANGE COVID-19 Severity" [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating changes in COVID-19 severity was terminated; results were posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-10-05Clinical Trial Update: PREDICT: A PBRN Feasibility Study on COVID-19 Screening in Dental Practice
A completed feasibility study (PREDICT) evaluated COVID-19 screening feasibility in dental practice; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-07-14Clinical Trial Update: Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 [Phase 4]
Phase 4 trial update on cyclosporine plus standard of care in hospitalized COVID-19 patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-07-11Clinical Trial Update: Efficacy of Hydroxychloroquine, Telmisartan and Azithromycin on the Survival of Hospitalized Elderly Patients With COVID-19 [Phase 3]
A Phase 3 clinical trial evaluating the efficacy of hydroxychloroquine, telmisartan, and azithromycin in hospitalized elderly patients with …
-
CLINICAL_TRIALS trial_result · 2022-07-06Clinical Trial Update: Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 Vaccine [Phase 2]
Phase 2 trial update evaluating a third dose vaccination with AstraZeneca or Pfizer COVID-19 vaccine in adults who previously received Sinov…
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: CRISIS2: A Phase 2 Study of the Safety and Antiviral Activity of Brequinar in Non-hospitalized Pts With COVID-19 [Phase 2]
Phase 2 trial assessing safety and antiviral activity of brequinar in non-hospitalized COVID-19 patients completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: COVID-19 Morbidity in Healthcare Workers and Vitamin D Supplementation [Phase 4]
Phase 4 clinical trial examining COVID-19 morbidity in healthcare workers and the effect of vitamin D supplementation; study completed.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Anakinra for COVID-19 Respiratory Symptoms [Phase 3]
Phase 3 trial of anakinra for COVID-19 respiratory symptoms has been terminated.
-
CLINICAL_TRIALS trial_result · 2020-12-24Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating an immunomodulatory therapy for moderate to severe COVID-19 has completed enrollment and results…
-
CLINICAL_TRIALS withdrawal · 2020-09-02Clinical Trial Update: Use of Dexmedetomidine in Light to Moderate Sedation in the Patient in the Palliative Situation of a Sars-cov-2 / COVID-19 Infection [Phase 4]
A Phase 4 trial evaluating dexmedetomidine for light to moderate sedation in palliative COVID-19 patients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Clazakizumab vs. Placebo - COVID-19 Infection [Phase 2]
Phase 2 clinical trial comparing clazakizumab to placebo in COVID-19 infection; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection [Phase 2]
Phase 2 trial update evaluating the efficiency and security of nivolumab therapy in obese individuals with COVID-19 infection.
-
CLINICAL_TRIALS research · 2020-05-12Clinical Trial Update: COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) [Phase 2, Phase 3]
Clinical trial update for COVID-19 convalescent plasma in symptomatic COVID-19 patients (FALP-COVID), spanning Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Immunity and Safety of Covid-19 Synthetic Minigene Vaccine [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the immunogenicity and safety of a Covid-19 synthetic minigene vaccine from Shenzhen Geno-Immune Medical Instit…